NASDAQ: CPRXCatalyst Pharmaceuticals Inc Stock Ownership - Who owns Catalyst Pharmaceuticals?
Insider buying vs selling
Have Catalyst Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-08 | 30,000 | $20.30 | $609.00kSell |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-08 | 112,475 | $2.24 | $251.94kBuy |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-04 | 30,000 | $19.52 | $585.60kSell |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-04 | 30,000 | $2.24 | $67.20kBuy |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-03 | 20,000 | $2.24 | $44.80kBuy |
| Brian Elsbernd | Chief ComplianceLegal Officer | 2025-09-03 | 20,000 | $20.08 | $401.60kSell |
| David S. Tierney | Director | 2025-08-27 | 50,000 | $2.24 | $112.00kBuy |
| Steve Miller | Chief Op. Scientific Officer | 2025-08-27 | 110,000 | $2.24 | $246.40kBuy |
| David S. Tierney | Director | 2025-08-27 | 26,000 | $20.20 | $525.20kSell |
| Steve Miller | Chief Op. Scientific Officer | 2025-08-26 | 115,000 | $2.24 | $257.60kBuy |
CPRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CPRX insiders and whales buy or sell their stock.
CPRX Shareholders
What type of owners hold Catalyst Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 15.44% | 18,900,438 | $397.10M | Institution |
| Vanguard Group Inc | 7.16% | 8,765,835 | $184.17M | Institution |
| Biomarin Pharmaceutical Inc | 5.45% | 6,666,667 | $140.07M | Insider |
| State Street Corp | 4.48% | 5,478,388 | $115.10M | Institution |
| Patrick J. McEnany | 3.86% | 4,719,467 | $99.16M | Insider |
| Hubert E. Md Huckel | 3.10% | 3,793,238 | $79.70M | Insider |
| Renaissance Technologies LLC | 2.66% | 3,251,516 | $68.31M | Institution |
| Morgan Stanley | 2.60% | 3,183,523 | $66.89M | Institution |
| Deerfield Management Company LP | 2.35% | 2,879,476 | $60.50M | Institution |
| Geode Capital Management LLC | 2.34% | 2,866,683 | $60.23M | Institution |
CPRX vs Biotech Stocks
Catalyst Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.